Literature DB >> 1616328

Inhibition by prostaglandin E1 and E2 of 1,25-dihydroxyvitamin D3 synthesis by synovial fluid macrophages from arthritic joints.

M E Hayes1, A Rai, R G Cooper, D Bayley, A J Freemont, E B Mawer.   

Abstract

Previous work has shown that renal metabolism of 25-dihydroxyvitamin D3 (25(OH)D3) to the active metabolite, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) is stimulated by prostaglandin E2 and inhibited by acetylsalicylate (aspirin). As prostaglandins are primary inflammatory mediators and synovial fluid macrophages are known to synthesise 1,25(OH)2D3 in vitro, the effects of prostaglandin E1, prostaglandin E2, and aspirin on the metabolism of 25(OH)D3 by cells cultured from synovial fluid of patients with inflammatory arthritis were investigated. Most cultures contained non-proliferating macrophages which formed 1,25(OH)2D3; however, two of 13 cultures contained colonies of rapidly proliferating fibroblast-like cells which formed 24,25(OH)2D3 (24,25(OH)2D3). Prostaglandin E1 and prostaglandin E2 (0.01-10 mumol/l) induced marked inhibition of 1,25(OH)2D3 synthesis (up to 94%) in a dose dependent manner after preincubations of 24 hours but not over straightforward six hour incubations. Exposure of macrophages to aspirin (1 mumol/l-1 mmol/l) for 24 hours did not affect 1,25(OH)2D3 synthesis unless the cells had been pretreated with lipopolysaccharides, in which instance 1 mM aspirin increased 1,25(OH)2D3 synthesis. Lipopolysaccharide is a macrophage activating factor which stimulates macrophages to form 1,25(OH)2D3, and it also induces prostaglandin synthesis which would be inhibited by aspirin. Taken together these results suggest that prostaglandin E1 and prostaglandin E2 synthesised by macrophages may act in an autocrine manner to attenuate the ability of macrophage activating factors, such as lipopolysaccharide, to stimulate 1,25(OH)2D3 synthesis. Prostaglandins synthesised by other inflammatory cells may also inhibit 1,25(OH)2D3 synthesis in a paracrine manner. In contrast, prostaglandin E2 and aspirin had limited effects on fibroblast 24,25(OH)2D3 synthesis. This study shows that the effects of prostaglandin E1, prostaglandin E2, and aspirin in macrophages contrast with those previously reported for the renal 25(OH)D3-1alpha-hydroxylase, where prostaglandin E2 stimulated and aspirin inhibited enzyme activity. These results further emphasise that synthesis of 1,25(OH)2D3 in non-renal sites is independently regulated, which is consistent with it having an immunological role at a local level rather than playing a part in systemic calcium homeostasis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1616328      PMCID: PMC1005696          DOI: 10.1136/ard.51.5.632

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  31 in total

Review 1.  Cytokines and eicosanoids in rheumatic diseases.

Authors:  S J Hopkins
Journal:  Ann Rheum Dis       Date:  1990-04       Impact factor: 19.103

Review 2.  The immunobiology of vitamin D.

Authors:  W F Rigby
Journal:  Immunol Today       Date:  1988-02

Review 3.  Basic and clinical concepts related to vitamin D metabolism and action (first of two parts).

Authors:  M R Haussler; T A McCain
Journal:  N Engl J Med       Date:  1977-11-03       Impact factor: 91.245

4.  Differential release of TNF-alpha, IL 1, and PGE2 by human blood monocytes subsequent to interaction with different bacterial derived agents.

Authors:  I J Fidler; A Nii; T Utsugi; D Brown; O Bakouche; E S Kleinerman
Journal:  Lymphokine Res       Date:  1990

5.  1,25-Dihydroxyvitamin D3 receptors in lymphocytes from patients with rheumatoid arthritis.

Authors:  S C Manolagas; D A Werntz; C D Tsoukas; D M Provvedini; J H Vaughan
Journal:  J Lab Clin Med       Date:  1986-12

6.  Metabolism of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 by blood derived macrophages from a patient with alveolar rhabdomyosarcoma during short-term culture and 1 alpha,25-dihydroxyvitamin D3 after long-term culture.

Authors:  M E Hayes; D Bayley; M Drayson; A J Freemont; J Denton; M Davies; E B Mawer
Journal:  J Steroid Biochem Mol Biol       Date:  1991-03       Impact factor: 4.292

7.  Abnormal vitamin D metabolism in Hodgkin's lymphoma.

Authors:  M Davies; E B Mawer; M E Hayes; G A Lumb
Journal:  Lancet       Date:  1985-05-25       Impact factor: 79.321

Review 8.  Nutrition, immune function, and inflammation: an overview.

Authors:  J M Wan; M P Haw; G L Blackburn
Journal:  Proc Nutr Soc       Date:  1989-09       Impact factor: 6.297

Review 9.  Eicosanoid metabolism by lymphocytes: do all human nucleated cells generate eicosanoids?

Authors:  M E Goldyne
Journal:  Pharmacol Res       Date:  1989 May-Jun       Impact factor: 7.658

10.  Evidence for nonrenal synthesis of 1,25-dihydroxyvitamin D in patients with inflammatory arthritis.

Authors:  E B Mawer; M E Hayes; P E Still; M Davies; G A Lumb; J Palit; P J Holt
Journal:  J Bone Miner Res       Date:  1991-07       Impact factor: 6.741

View more
  1 in total

1.  Autocrine control of vitamin D metabolism in synovial cells from arthritic patients.

Authors:  S J Smith; M E Hayes; P L Selby; E B Mawer
Journal:  Ann Rheum Dis       Date:  1999-06       Impact factor: 19.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.